Global Botulinum Toxin Market Report 2018: Size, Trends and Forecasts 2017-2021 Featuring Allergan Plc, Ipsen & Revance Therapeutics, Inc - ResearchAndMarkets.com

DUBLIN--()--The "Global Botulinum Toxin Market: Size, Trends and Forecasts (2017-2021)" report has been added to ResearchAndMarkets.com's offering.

Global Botulinum Toxin Market: Size, Trends and Forecasts (2017-2021) provides an in-depth analysis of the global botulinum toxin market with detailed analysis of the actual and the expected market size along with the market size of each market segment on the basis of application, products as well as regional.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.

The major growth drivers for the botulinum toxin market are: aging population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.

The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.

Market Dynamics

Growth Drivers

  • Aging Population
  • Escalating Number of Plastic Surgeons
  • Upsurge in Facial Aesthetics Procedures
  • Rising Alternative of Non-Surgical Procedures
  • Increasing Healthcare Spending in Emerging Markets

Challenges

  • Potential Health Risk Associated with Botulinum Toxin
  • Botulinum Toxins As Bio-terror Threat

Market Trends

  • Rise In Medical Tourism
  • Reduced Safety Concerns and Simple & Instant Characteristic

Country Coverage

  • The US
  • Europe
  • Japan
  • Asia (excluding Japan)
  • Korea

Company Coverage

  • Allergan Plc.
  • Ipsen
  • Revance Therapeutics, Inc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Market Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiles

  • Allergan Plc.
  • Ipsen
  • Revance Therapeutics, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/c28vxv/global_botulinum?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs